Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in Sjögren's syndrome.

Roland Jonsson1, Ketil Moen, Didrik Vestrheim

  • 1Broegelmann Research Laboratory, University of Bergen, Norway. roland.jonsson@gades.uib.no

Oral Diseases
|July 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial gene expression of salivary glands in Sjögren's disease highlights T follicular helper cell signalling as an indicator of disease pathogenesis.

RMD open·2026
Same author

Targeting autoimmunity: Phosphodiesterase inhibitors as immunomodulators-a review of current insights and future direction.

Autoimmunity reviews·2026
Same author

A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease.

Annals of the rheumatic diseases·2025
Same author

Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial.

Trials·2025
Same author

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).

Annals of the rheumatic diseases·2025
Same author

2023 International Rome consensus for the nomenclature of Sjögren disease.

Nature reviews. Rheumatology·2025
Same journal

Structural Validity and Factorial Analysis of the Brazilian Oral Health Impact Profile for Temporomandibular Disorders Instrument.

Oral diseases·2026
Same journal

Effects of Pistacia lentiscus Leaf-Twig and Resin (Mastic) Oils on Salivary Flow in Healthy Individuals.

Oral diseases·2026
Same journal

Oral Delivery of Bioencapsulated CTB-Pro-IGF-1 Enhances Bone Regeneration in a Pre-Clinical Rat Model of Jaw Osteoradionecrosis.

Oral diseases·2026
Same journal

Trends in Stage and Age at Diagnosis of Oral Squamous Cell Carcinoma Over Time: A Systematic Review and Meta-Analysis.

Oral diseases·2026
Same journal

Ion Channel Dysfunction and Therapeutic Targeting in Salivary Gland Disorders.

Oral diseases·2026
Same journal

Authors' Reply "Synchronous Soft-Tissue Lesions in the Oral Cavity in an Adolescent".

Oral diseases·2026
See all related articles

Sjögren's syndrome, an autoimmune disorder causing dry symptoms, lacks simple diagnostic tests. New criteria and identifying autoantibodies against muscarinic M3 receptors advance understanding of glandular and autonomic dysfunction in this rheumatic disease.

Area of Science:

  • Rheumatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Sjögren's syndrome is a chronic autoimmune rheumatic disorder characterized by sicca symptoms due to impaired exocrine secretions.
  • Current diagnostic methods lack simplicity, necessitating the development of refined classification criteria.
  • Autoantibodies are frequently detected in Sjögren's syndrome, with some correlating to disease severity.

Purpose of the Study:

  • To present a new set of classification criteria for Sjögren's syndrome developed through international collaboration.
  • To highlight the significance of autoantibodies, particularly those targeting the muscarinic M3 receptor, in understanding disease pathogenesis.
  • To discuss the implications of these findings for diagnosing and managing glandular and autonomic dysfunction in Sjögren's syndrome.

Related Experiment Videos

Main Methods:

  • Review and presentation of a newly developed set of classification criteria for Sjögren's syndrome.
  • Analysis of the role of various autoantibodies, including those against the muscarinic M3 receptor, in Sjögren's syndrome.
  • Discussion of the correlation between autoantibodies and disease extent/severity.

Main Results:

  • A new set of classification criteria for Sjögren's syndrome has been introduced via a joint European and USA research effort.
  • Serum autoantibodies targeting the muscarinic M3 receptor represent a significant advancement in understanding Sjögren's pathogenesis.
  • These autoantibodies are linked to impaired glandular function and autonomic dysfunction observed in some patients.

Conclusions:

  • The newly proposed classification criteria aim to improve the diagnosis of Sjögren's syndrome.
  • Identification of muscarinic M3 receptor autoantibodies offers insights into the mechanisms underlying Sjögren's syndrome.
  • Current treatment for primary Sjögren's syndrome remains primarily symptomatic, underscoring the need for further therapeutic advancements.